| 產品編號 |
bs-43049P |
| 英文名稱 |
Recombinant SARS-Cov-2 Spike S1 protein (T19R, G142D, del157/158, L452R, T478K, D614G, P681R), His (HEK293)
|
| 中文名稱 |
重組SARS冠狀病毒2 Spike突變蛋白S1(T19R, G142D, del157/158, L452R, T478K, D614G, P681R) |
| 別 名 |
SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein S1; Surface glycoprotein; Spike protein RBD; SPIKE_SARS2; 2019-nCOV Spike S1(T19R, G142D, del157/158, L452R, T478K, D614G, P681R), Recombinant (His Tag). ;Recombinant SAR 新冠病毒S蛋白; 新冠S蛋白; 新冠S1蛋白; SARS-CoV-2 S1蛋白; |
| 理論分子量 |
73 kDa |
| 檢測分子量 |
110-130 |
| 性 狀 |
Lyophilized or Liquid |
| 濃 度 |
＞0.5 mg/ml |
| 物 種 |
SARS-Cov-2 |
| 序 列 |
14-685/1273 |
| 純 度 |
>90% as determined by SDS-PAGE |
| 純化方法 |
AC |
| 內毒素 |
Not analyzed |
| 表達系統(tǒng) |
HEK293 cell |
| 活性 |
Yes |
| 標簽 |
His |
| 緩 沖 液 |
PBS (pH7.4). |
| 保存條件 |
Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事項 |
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產品介紹 |
The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.
|
| 產品圖片 |
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
|
|
|
